Navigation Links
International team identifies 21 new genetic risk factors for Crohn's disease
Date:6/29/2008

An international consortium of Crohn's disease researchers has combined data from three independent studies to identify 21 new genetic variants associated with the inflammatory bowel disorder, bringing the total number of risk factors to 32. Several of these are involved with the immune system's inital response to pathogens, supporting earlier evidence that disruptions in a process called autophagy may lead to the disorder's characteristic immune system overactivity. The report will appear in the journal Nature Genetics and is receiving early online release.

"This greatly increases our knowledge of the genetic architecture of Crohn's and gives us more detailed insight into the biological underpinnings of the disease," says Mark Daly, PhD, of the Massachusetts General Hospital (MGH) Center for Human Genetic Research and the Broad Institute of MIT and Harvard, the report's senior author. "Better understanding of the precise functions of these genes and the molecular effects of Crohn's-associated variants should lead us to novel strategies for therapies and, someday, prevention."

In 2007 three separate research teams a North American-based team, involving Daly and colleagues at six other institutions and clinical sites; a U.K. team supported by the Wellcome Trust; and a group of French and Belgian investigators each published genome-wide association studies (GWAS) of Crohn's disease that, combined with earlier studies, brought the total number of Crohn's-associated gene sites to 11. Those explained only a small proportion of the heritability of Crohn's, which affects nearly half a million people in the U.S.

Since the power of any GWAS is limited by the number of samples available for screening, the three teams combined their data through a process called meta-analysis, allowing the comparison of data from more than 3,200 Crohn's patients with more than 4,800 controls. That was supplemented by an analysis of new data from an additional 3,700 patients and matching controls.

Both of those analyses strongly confirmed the 11 previously-identified sites and found an additional 21 areas associated with susceptibility to Crohn's. While the newly identified sites are not as strong as those found in earlier studies, they continue to build a picture of factors leading to the inappropriate immune-system activation that characterizes the disorder.

"It's amazing that all of the genes indentified in GWAS studies of Crohn's so far align with the pathways that we know are disrupted, systems that sense the presence of microbes and effectively clear them from the body." says Ramnik Xavier, MD, of the Center for the Study of Inflammatory Bowel Disease in the MGH Gastroenterology Unit and the MGH Center for Computational and Integrative Biology, a co-author of the Nature Genetics study. "Mapping the internal circuitry of these systems and identifying the molecular switches that control those circuits should lead to better targeted drugs for Crohn's and other inflammatory bowel diseases." Daly is an assistant professor of Medicine at Harvard Medical School and Xavier is an associate professor.


'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Related biology news :

1. 2008 ASABE Annual International Meeting
2. The 12th International Behavioral Ecology Congress held at Cornell University, Aug. 10-14
3. Biotechnology key to developing sustainable industries says international panel
4. BBVA Foundation international study on attitudes to stem cell research
5. International symposium explores fire suppression economics
6. International workshop to address capacity building for rainforest leaders
7. Great Ape Trust to gather internationally recognized scientists for Decade of the Mind III
8. Major international collaboration offers new clues to genetics of type 2 diabetes
9. DHS Begins Collecting 10 Fingerprints From International Visitors at New Yorks John F. Kennedy International Airport
10. Presidents science adviser to address IEEE International Homeland Security Conference
11. International team announces discovery of massive Jurassic marine reptile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
Breaking Biology News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017   Montrium , a growing leader ... exciting new partnership with a groundbreaking non-profit research organization, Multidisciplinary ... ... psychotherapy studies for PTSD ... recently granted Breakthrough Therapy Designation to MDMA for the treatment of ...
(Date:9/14/2017)... ... September 14, 2017 , ... ... pharma and biotech at the third annual DrugDev Summit, November 7-8, 2017 in ... the world’s most progressive clinical research leaders for best practice case studies, keynote ...
(Date:9/14/2017)... (PRWEB) , ... September 14, 2017 , ... AIM Global, ... Medical Tracking Systems Inc. has won the 2017 Case Study Competition for AIDC. ... which provide benefits that decrease risk” and push the adoption of automated data collection ...
(Date:9/12/2017)... Brunswick, NJ (PRWEB) , ... September 12, 2017 ... ... one of the fastest growing b2b product testing and development companies will be ... expanded service offerings. , Contract Pharma is an educational ...
Breaking Biology Technology: